Journal of Molecular Neuroscience

Genetic and environmental epidemiology of Alzheimer's disease in arabs residing in Israel
pp. 207-212(6)
Authors: Farrer, Lindsay; Friedland, Robert; Bowirrat, Abdalla; Waraska, Kristin; Korczyn, Amos; Baldwin, Clinton

Enhancing brain and cognitive function of older adults through fitness training
pp. 213-221(9)
Authors: Kramer, Arthur; Colcombe, Stanley; McAuley, Edward; Eriksen, Kirk; Scalf, Paige; Jerome, Gerald; Marquez, David; Elavsky, Steriani; Webb, Andrew

Relationship between the induction of RAGE cell-surface antigen and the expression of amyloid binding sites
pp. 223-232(10)
Authors: Mruthinti, Shyamala; Hill, William; Swamy-Mruthinti, Satyanarayana; Buccafusco, Jerry

β-secretase processing of the Alzheimer's amyloid protein precursor (APP)
pp. 233-239(7)
Authors: Marlow, Laura; Cain, Melissa; Pappolla, Miguel; Sambamurti, Kumar

Hippocampal volume is associated with memory but not nonmemory cognitive performance in patients with mild cognitive impairment
pp. 241-248(8)
Authors: Grundman, Michael; Jack, Clifford; Petersen, Ronald; Kim, Hyun; Taylor, Curtis; Datvian, Marina; Weiner, Myron; DeCarli, Charles; DeKosky, Steven; Dyck, Christopher; Darvesh, Sultan; Yaffe, Kristine; Kaye, Jeffrey; Ferris, Steven; Thomas, Ronald; Thal, Leon

Characterization of radioiodinated ligand binding to amyloid β plaques
pp. 249-253(5)
Authors: Kung, Mei-Ping; Zhuang, Zhi-Ping; Hou, Catherine; Jin, Lee-Way; Kung, Hank

Effects of lipophilicity on the affinity and nonspecific binding of iodinated benzothiazole derivatives
pp. 255-260(6)
Authors: Wang, Yanming; Mathis, Chester; Huang, Guo-Feng; Debnath, Manik; Holt, Daniel; Shao, Li; Klunk, William

Peptide nucleic acids targeted to the amyloid precursor protein
pp. 261-265(5)
Authors: McMahon, Beth; Stewart, Jennifer; Fauq, Abdul; Younkin, Steven; Younkin, Linda; Richelson, Elliott

Drug discovery targeted to the Alzheimer's APP mRNA 5′-untranslated region: The action of paroxetine and dimercaptopropanol
pp. 267-275(9)
Authors: Payton, Sandra; Cahill, Catherine; Randall, Jeffrey; Gullans, Steven; Rogers, Jack

Potential use of estrogen-like drugs for the prevention of Alzheimer's disease
pp. 277-281(5)
Authors: Smith, Jonathan; Levin-Allerhand, Justine

Immunological approach for the treatment of Alzheimer's disease
pp. 283-286(4)
Author: Solomon, Beka

The possible role of tissue-type plasminogen activator (tPA) and tPA blockers in the pathogenesis and treatment of Alzheimer's disease
pp. 287-289(3)
Authors: Melchor, Jerry; Pawlak, Robert; Chen, Zulin; Strickland, Sidney

Novel glycosaminoglycan precursors as anti-amyloid agents, Part III
pp. 291-297(7)
Authors: Kisilevsky, Robert; Szarek, Walter; Ancsin, John; Bhat, Shridhar; Li, Zhanjiang; Marone, Sandra

Study of memapsin 2 (β-secretase) and strategy of inhibitor design
pp. 299-304(6)
Authors: Tang, Jordan; Ghosh, Arun; Hong, Lin; Koelsch, Gerald; Turner, Robert; Chang, Wanpin

Femtomole immunodetection of synthetic and endogenous amyloid-β oligomers and its application to Alzheimer's disease drug candidate screening
pp. 305-313(9)
Authors: Chang, Lei; Bakhos, Lara; Wang, Zhiqiang; Venton, Duane; Klein, William

From vasoactive intestinal peptide (VIP) through activity-dependent neuroprotective protein (ADNP) to NAP: A view of neuroprotection and cell division
pp. 315-322(8)
Authors: Gozes, Illana; Divinsky, Inna; Pilzer, Inbar; Fridkin, Mati; Brenneman, Douglas; Spier, Avron

Alzheimer's therapeutics: Neurotrophin domain small molecule mimetics
pp. 323-326(4)
Authors: Massa, Stephen; Xie, Youmei; Longo, Frank

Apolipoprotein E-related neurotoxicity as a therapeutic target for Alzheimer's disease
pp. 327-337(11)
Authors: Marques, Marcos; Crutcher, Keith

Overcoming the blood-brain barrier to taxane delivery for neurodegenerative diseases and brain tumors
pp. 339-343(5)
Authors: Rice, Antonie; Michaelis, Mary; Georg, Gunda; Liu, Yanbin; Turunen, Brandon; Audus, Kenneth

Structure-based rational design of chemical ligands for AMPA-subtype glutamate receptors
pp. 345-348(4)
Authors: Zeng, Lei; Chen, Can; Muller, Michaela; Zhou, Ming-Ming

M₁ muscarinic agonists can modulate some of the hallmarks in Alzheimer's disease: Implications in future therapy
pp. 349-356(8)
Authors: Fisher, Abraham; Pittel, Zipora; Haring, Rachel; Bar-Ner, Nira; Kliger-Spatz, Michal; Natan, Niva; Egozi, Inbal; Sonego, Hagar; Marcovitch, Itzhak; Brandeis, Rachel

Calpain inhibitors, a treatment for alzheimer's disease: Position paper
pp. 357-362(6)
Authors: Battaglia, Fortunato; Trinchese, Fabrizio; Liu, Shumin; Walter, Sean; Nixon, Ralph; Arancio, Ottavio

Progress toward a high-affinity allosteric enhancer at muscarinic M₁ receptors
pp. 363-367(5)
Authors: Lazareno, Sebastian; Popham, Angela; Birdsall, Nigel

Acetylcholinesterase: A multifaceted target for structure-based drug design of anticholinesterase agents for the treatment of Alzheimer's disease
pp. 369-383(15)
Authors: Greenblatt, Harry; Dvir, Hay; Silman, Israel; Sussman, Joel

Steroid hormones and cognitive functioning in aging men: A mini-review
pp. 385-393(9)
Author: Sherwin, Barbara

Changes in apolipoprotein E expression in response to dietary and pharmacological modulation of cholesterol
pp. 395-406(12)
Authors: Petanceska, Suzana; DeRosa, Steven; Sharma, Ali; Diaz, Nichole; Duff, Karen; Tint, Steven; Refolo, Lorenzo; Pappolla, Miguel

A position paper: Based on observational data indicating an increased rate of altered blood chemistry requiring withdrawal from the Alzheimer's disease cholesterol-lowering treatment trial (ADCLT)
pp. 407-410(4)
Authors: Sparks, D.; Lopez, Jean; Connor, Don; Sabbagh, Marwan; Seward, Jim; Browne, Patrick

Discovery of a new class of synthetic protein kinase inhibitors that suppress selective aspects of glial activation and protect against β-amyloid induced injury: A foundation for future medicinal chemistry efforts focused on targeting Alzheimer's disease progression
pp. 411-423(13)
Authors: Watterson, D.; Velentza, Anastasia; Zasadzki, Magdalena; Craft, Jeffrey; Haiech, Jacques; Eldik, Linda

Alzheimer neurofibrillary degeneration: Therapeutic targets and high-throughput assays
pp. 425-429(5)
Authors: Iqbal, Khalid; Alonso, Alejandra; El-Akkad, Ezzat; Gong, Cheng-Xin; Haque, Niloufar; Khatoon, Sabiha; Pei, Jin-Jing; Tanimukai, Hitoshi; Tsujio, Ichiro; Wang, Jian-Zhi; Inge, Grundke-Iqbal